Evidence map›Paper›PMID 35291930›Full record

ArticlemAbs

The Fab portion of immunoglobulin G has sites in the CL domain that interact with Fc gamma receptor IIIa.

Yuki Yamaguchi, Natsumi Wakaizumi, Mine Irisa, Takahiro Maruno, Mari Shimada, Koya Shintani, Haruka Nishiumi, Rina Yogo, Saeko Yanaka, Daisuke Higo and 3 more

Open access · goldAbstract read
In one paragraph

Article in mAbs. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Generation of non-genetically modified, CAR-like, NK cells.Journal for immunotherapy of cancer · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Yuki YamaguchiGraduate School of Engineering, Osaka University, Osaka, Japan.ORCID 0000-0001-7856-4031
Natsumi WakaizumiGraduate School of Engineering, Osaka University, Osaka, Japan.ORCID 0000-0002-8179-0475
Mine IrisaGraduate School of Engineering, Osaka University, Osaka, Japan.ORCID 0000-0003-4319-1735
Takahiro MarunoGraduate School of Engineering, Osaka University, Osaka, Japan.ORCID 0000-0003-1099-2536
Mari ShimadaGraduate School of Engineering, Osaka University, Osaka, Japan.
Koya ShintaniGraduate School of Engineering, Osaka University, Osaka, Japan.
Haruka NishiumiGraduate School of Engineering, Osaka University, Osaka, Japan.ORCID 0000-0003-1862-4543
Rina YogoExploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences, Aichi, Japan.ORCID 0000-0002-1595-0194
Saeko YanakaExploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences, Aichi, Japan.ORCID 0000-0002-3513-5701
Daisuke HigoThermo Fisher Scientific, Kanagawa, Japan.
Tetsuo TorisuGraduate School of Engineering, Osaka University, Osaka, Japan.ORCID 0000-0002-8269-7803
Koichi KatoExploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences, Aichi, Japan.ORCID 0000-0001-7187-9612
Susumu UchiyamaGraduate School of Engineering, Osaka University, Osaka, Japan.ORCID 0000-0002-5181-179X
The University of Osaka · JPNational Institutes of Natural Sciences · JPThermo Fisher Scientific (Japan) · JP

Funding

ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
NIGMS NIH HHS R01 GM129325
6 · The paper itself

Abstract

The interaction between IgG and Fc gamma receptor IIIa (FcγRIIIa) is essential for mediating immune responses. Recent studies have shown that the antigen binding fragment (Fab) and Fc are involved in IgG-FcγRIII interactions. Here, we conducted bio-layer interferometry (BLI) and isothermal titration calorimetry to measure the kinetic and thermodynamic parameters that define the role of Fab in forming the IgG-FcγRIII complex using several marketed therapeutic antibodies. Moreover, hydrogen/deuterium exchange mass spectrometry (HDX-MS) and crosslinking mass spectrometry (XL-MS) were used to clarify the interaction sites and structural changes upon formation of these IgG-FcγRIII complexes. The results showed that Fab in IgG facilitates the interaction via slower dissociation and a larger enthalpy gain. However, a larger entropy loss led to only a marginal change in the equilibrium dissociation constant. Combined HDX-MS and XL-MS analysis revealed that the CL domain of Fab in IgG was in close proximity to FcγRIIIa, indicating that this domain specifically interacts with the extracellular membrane-distal domain (D1) and membrane-proximal domain (D2) of FcγRIIIa. Together with previous studies, these results demonstrate that IgG-FcγRIII interactions are predominantly mediated by the binding of Fc to D2, and the Fab-FcγRIII interaction stabilizes complex formation. These interaction schemes were essentially fucosylation-independent, with Fc-D2 interactions enhanced by afucosylation and the contribution of Fab slightly reduced. Furthermore, the influence of antigen binding on IgG-FcγRIII interactions was also investigated. Combined BLI and HDX-MS results indicate that structural alterations in Fab caused by antigen binding facilitate stabilization of IgG-FcγRIII interactions. This report provides a comprehensive understanding of the interaction between IgG and FcγRIII.

Indexed as

Immunoglobulin GReceptors, IgGGlycosylationHydrogen Deuterium Exchange-Mass SpectrometryImmunoglobulin Fab FragmentsImmunoglobulin Fc FragmentsImmunoglobulin Fab FragmentsImmunoglobulin Fc FragmentsImmunoglobulin GReceptors, IgGantibodyantigen-bindingbio-layer interferometrycrosslinking mass spectrometryFcγRIIIhydrogen/deuterium exchange mass spectrometryIgGisothermal titration calorimetry

Identifiers

PMID35291930
PMCPMC8932917
OpenAlexW4221004728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.